Abstract

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2020 - Volume 24, Number 1

Page(s): 57

Download in electronic PDF format for $75
  • Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Page 1

Abstract

A formulation for preparing Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • hydrocortisone
  • iodoquinol
  • metronidazole
  • zinc oxide
  • skin disorders
  • corticosteroid
  • inflammation
  • anti-inflammatory agent
  • amebicide
  • antibiotic
  • bacterial infection
  • antimicrobial agent
  • topical preparation
  • dermal protection

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2020
Pg. 57
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Sep/Oct 2022
Pg. 430
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Author(s): Allen Loyd V Jr
Sep/Oct 2002
Pg. 365
Zinc Oxide 20% Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Sep/Oct 2007
Pg. 423
Hydrocortisone 0.5% Ethanolic Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Sep/Oct 2023
Pg. 422-423
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 372-377
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Author(s): Riepl Mike
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 1999
Pg. 225
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 185
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2013
Pg. 380-383
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Author(s): McElhiney Linda F
Jul/Aug 2008
Pg. 364
Zirconium Oxide Lotion
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 259-261
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Author(s): Gupta Vishnu D
Nov/Dec 2011
Pg. 503
Lavender Oil 4% in Polyethylene Glycol Ointment
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H